BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35546701)

  • 21. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis.
    Wang L; Lin Y; Yuan Y; Liu F; Sun K
    Biochem Genet; 2021 Oct; 59(5):1278-1294. PubMed ID: 33786672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.
    Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z
    Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Analysis of Novel Biomarkers Involved in Chromophobe Renal Cell Carcinoma by Integrated Bioinformatics Analyses.
    Zhang W; Xu Y; Zhang J; Wu J
    Biomed Res Int; 2020; 2020():2671281. PubMed ID: 32090070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-protein interaction analysis of distinct molecular pathways in two subtypes of colorectal carcinoma.
    Chen H; Fang Y; Zhu H; Li S; Wang T; Gu P; Fang X; Wu Y; Liang J; Zeng Y; Zhang L; Qiu W; Zhang L; Yi X
    Mol Med Rep; 2014 Dec; 10(6):2868-74. PubMed ID: 25242495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
    Guo T; Hou D; Yu D
    Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
    Wu F; Wu S; Gou X
    Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
    Wei J; Wang Y; Shi K; Wang Y
    Biomed Res Int; 2020; 2020():8959210. PubMed ID: 32258155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of key genes and functions of circulating tumor cells in multiple cancers through bioinformatic analysis.
    Guan Y; Xu F; Wang Y; Tian J; Wan Z; Wang Z; Chong T
    BMC Med Genomics; 2020 Sep; 13(1):140. PubMed ID: 32972417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.
    Chen Q; Hu J; Deng J; Fu B; Guo J
    Biomed Res Int; 2019; 2019():3917982. PubMed ID: 31828101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.